Herbalife (HLF) Financials

$6.86 -0.43 (-5.84%)

Closing price 05/6/2025 03:59 PM Eastern

Extended Trading

$6.89 +0.03 (+0.51%)

As of 08:02 AM Eastern

Annual Income Statements for Herbalife

This table shows Herbalife's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	309	339	260	214	297	280	373	447	321	142	254
Consolidated Net Income / (Loss)	309	339	260	214	297	311	373	447	321	142	254
Net Income / (Loss) Continuing Operations	309	339	260	214	297	280	373	447	321	142	254
Total Pre-Tax Income	421	486	365	471	464	451	516	561	425	203	169
Total Operating Income	514	584	458	617	683	568	641	734	545	356	386
Total Gross Profit	3,976	3,613	3,634	3,579	3,973	3,919	4,391	4,564	4,031	3,871	3,889
Total Revenue	4,959	4,469	4,488	4,428	4,892	4,877	5,542	5,803	5,204	5,062	4,993
Operating Revenue	4,959	4,469	4,488	4,428	4,892	4,877	5,542	5,803	5,204	5,062	4,993
Total Cost of Revenue	983	856	855	849	919	958	1,151	1,239	1,174	1,191	1,104
Operating Cost of Revenue	983	856	855	849	919	958	1,151	1,239	1,174	1,191	1,104
Total Operating Expenses	3,462	3,029	3,176	2,962	3,289	3,351	3,751	3,829	3,486	3,515	3,503
Selling, General & Admin Expense	1,991	1,785	1,967	1,759	1,955	1,940	2,075	2,012	1,810	1,866	1,875
Other Operating Expenses / (Income)	1,471	1,245	1,209	1,203	1,334	1,411	1,676	1,817	1,675	1,649	1,628
Total Other Income / (Expense), net	-92	-97	-93	-146	-219	-148	-124	-173	-120	-153	-217
Interest Expense	92	101	99	161	181	153	133	153	139	166	218
Interest & Investment Income	13	5.60	5.90	15	19	21	8.80	4.40	6.10	12	12
Other Income / (Expense), net	-13	-2.30	-	0.40	-57	-16	0.00	-25	13	1.00	-11
Income Tax Expense	113	147	105	257	168	140	144	114	104	61	-85
Basic Earnings per Share	$3.58	$4.11	$1.57	$1.35	$2.12	$2.26	$2.83	$4.22	$3.26	$1.44	$2.53
Weighted Average Basic Shares Outstanding	86.30M	82.60M	166.10M	158.50M	140.20M	137.40M	131.50M	105.90M	98.50M	99M	100.60M
Diluted Earnings per Share	$3.40	$3.97	$1.51	$1.29	$1.98	$2.20	$2.77	$4.13	$3.23	$1.42	$2.50
Weighted Average Diluted Shares Outstanding	90.80M	85.30M	172.20M	165.70M	149.50M	141.60M	134.50M	108.30M	99.50M	100.20M	101.60M
Weighted Average Basic & Diluted Shares Outstanding	86.20M	82.50M	83.10M	158.40M	139.90M	147.53M	117.92M	109.77M	97.92M	99.26M	101.20M

This table shows Herbalife's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	82	54	29	60	43	10	24	4.70	47	178
Consolidated Net Income / (Loss)	82	54	29	60	43	10	24	4.70	47	178
Net Income / (Loss) Continuing Operations	82	54	29	60	43	10	24	4.70	47	178
Total Pre-Tax Income	113	64	31	85	69	18	34	12	71	53
Total Operating Income	147	89	71	123	107	56	72	80	127	107
Total Gross Profit	1,010	915	954	1,012	978	927	979	998	972	940
Total Revenue	1,295	1,181	1,252	1,314	1,281	1,215	1,264	1,281	1,240	1,207
Operating Revenue	1,295	1,181	1,252	1,314	1,281	1,215	1,264	1,281	1,240	1,207
Total Cost of Revenue	285	266	299	302	303	288	285	283	269	268
Operating Cost of Revenue	285	266	299	302	303	288	285	283	269	268
Total Operating Expenses	863	826	883	889	871	872	907	918	845	833
Selling, General & Admin Expense	448	437	476	461	455	474	492	502	444	437
Other Operating Expenses / (Income)	414	389	407	429	416	397	415	415	401	397
Total Other Income / (Expense), net	-35	-25	-39	-38	-38	-38	-38	-68	-57	-54
Interest Expense	35	43	39	38	39	50	38	58	57	66
Income Tax Expense	31	10	1.80	25	26	7.50	9.70	7.50	23	-125
Basic Earnings per Share	$0.84	$0.56	$0.30	$0.60	$0.43	$0.11	$0.24	$0.05	$0.47	$1.77
Weighted Average Basic Shares Outstanding	98M	98.50M	98.50M	99.10M	99.20M	99M	99.70M	100.60M	100.90M	100.60M
Diluted Earnings per Share	$0.83	$0.56	$0.29	$0.60	$0.43	$0.10	$0.24	$0.05	$0.46	$1.75
Weighted Average Diluted Shares Outstanding	98.80M	99.50M	100.20M	99.50M	100.40M	100.20M	100.70M	101.70M	101.90M	101.60M
Weighted Average Basic & Diluted Shares Outstanding	97.88M	97.92M	98.92M	99.00M	99.11M	99.26M	99.97M	100.72M	100.79M	101.20M

This table details how cash moves in and out of Herbalife's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-328	244	-27	410	-29	-368	207	-444	-94	79	-157
Net Cash From Operating Activities	511	629	367	591	648	458	629	460	353	358	285
Net Cash From Continuing Operating Activities	511	629	367	591	648	458	629	460	353	358	285
Net Income / (Loss) Continuing Operations	309	339	260	214	297	311	373	447	321	142	254
Consolidated Net Income / (Loss)	309	339	260	214	297	311	373	447	321	142	254
Depreciation Expense	93	98	98	100	100	98	100	108	115	113	121
Amortization Expense	44	56	56	60	64	44	27	30	6.70	7.40	13
Non-Cash Adjustments To Reconcile Net Income	288	108	48	73	139	63	148	145	53	82	105
Changes in Operating Assets and Liabilities, net	-222	28	-95	144	48	-58	-19	-269	-143	13	-208
Net Cash From Investing Activities	-201	-73	-142	-95	-84	-108	-123	-156	-156	-135	-85
Net Cash From Continuing Investing Activities	-201	-73	-142	-95	-84	-108	-123	-156	-156	-135	-85
Purchase of Property, Plant & Equipment	-189	-79	-143	-96	-84	-106	-112	-151	-156	-135	-122
Other Investing Activities, net	-	5.70	1.00	0.30	0.10	-1.90	-11	-5.00	0.20	0.20	37
Net Cash From Financing Activities	-390	-250	-252	-85	-593	-713	-321	-729	-265	-148	-335
Net Cash From Continuing Financing Activities	-390	-250	-252	-85	-593	-713	-321	-729	-265	-148	-335
Repayment of Debt	-160	-234	-439	-517	-1,850	-696	-29	-988	-960	-353	-2,500
Repurchase of Common Equity	-1,292	-17	-13	-844	-750	-17	-924	-1,011	-147	-11	-8.30
Issuance of Debt	1,203	0.40	200	1,276	1,951	0.00	632	1,271	842	215	2,173
Effect of Exchange Rate Changes	-248	-61	-	-	-	-4.00	22	-19	-	4.80	-23
Cash Interest Paid	39	51	45	101	106	114	79	144	134	159	194
Cash Income Taxes Paid	181	168	163	159	159	148	138	156	145	133	147

This table details how cash moves in and out of Herbalife's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-49	-24	-55	86	-31	80	-183	-23	29	20
Net Cash From Operating Activities	70	54	46	136	80	96	14	103	100	70
Net Cash From Continuing Operating Activities	70	54	46	136	80	96	14	103	100	70
Net Income / (Loss) Continuing Operations	82	54	29	60	43	10	24	4.70	47	178
Consolidated Net Income / (Loss)	82	54	29	60	43	10	24	4.70	47	178
Depreciation Expense	29	28	28	29	28	28	29	33	31	29
Amortization Expense	1.70	1.70	1.70	1.90	1.90	1.90	2.10	3.50	3.80	4.00
Non-Cash Adjustments To Reconcile Net Income	21	7.70	-3.80	26	26	34	-11	45	44	27
Changes in Operating Assets and Liabilities, net	-64	-38	-8.60	19	-20	22	-31	17	-26	-168
Net Cash From Investing Activities	-38	-43	-30	-38	-31	-35	-33	-36	10	-26
Net Cash From Continuing Investing Activities	-38	-43	-30	-38	-31	-35	-33	-36	10	-26
Purchase of Property, Plant & Equipment	-38	-43	-30	-38	-31	-35	-33	-36	-27	-26
Other Investing Activities, net	0.10	-	0.10	-	-	0.10	0.10	0.10	37	0.10
Net Cash From Financing Activities	-56	-50	-76	-9.30	-71	8.30	-158	-82	-86	-9.00
Net Cash From Continuing Financing Activities	-56	-50	-76	-9.30	-71	8.30	-158	-82	-86	-9.00
Repayment of Debt	-330	-458	-138	-8.60	-195	-11	-317	-1,658	-242	-283
Repurchase of Common Equity	-0.10	-0.10	-8.70	-0.70	-0.30	-1.30	-2.30	-3.40	-	-2.60
Issuance of Debt	274	409	71	-	124	20	161	1,579	156	277
Effect of Exchange Rate Changes	-25	-	5.50	-2.50	-	-	-	-	-	-15

This table presents Herbalife's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,355	2,478	2,565	2,895	2,790	2,679	3,076	2,820	2,732	2,809	2,728
Total Current Assets	1,393	1,566	1,463	1,860	1,805	1,488	1,776	1,432	1,356	1,399	1,144
Cash & Equivalents	645	890	844	1,279	1,199	839	1,045	602	508	575	415
Accounts Receivable	84	70	70	93	71	80	83	67	71	81	69
Inventories, net	378	332	371	341	382	436	501	576	581	505	475
Prepaid Expenses	186	161	177	147	154	133	146	188	197	238	184
Plant, Property, & Equipment, net	367	339	378	378	360	372	390	442	486	507	460
Total Noncurrent Assets	595	572	725	657	625	819	910	946	890	904	1,124
Goodwill	102	92	90	97	93	92	101	95	93	95	88
Intangible Assets	310	310	310	310	310	310	313	317	316	314	312
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	-	-	179	399
Other Noncurrent Operating Assets	155	141	325	250	222	417	496	533	481	315	326
Total Liabilities & Shareholders' Equity	2,355	2,478	2,565	2,895	2,790	2,679	3,076	2,820	2,732	2,809	2,728
Total Liabilities	2,689	2,531	2,369	3,230	3,513	3,069	3,932	4,211	3,998	3,870	3,529
Total Current Liabilities	875	1,024	792	907	1,589	964	1,127	1,080	977	1,278	1,230
Short-Term Debt	100	230	9.50	102	679	24	23	29	30	310	284
Accounts Payable	72	71	66	68	81	82	89	92	90	84	70
Accrued Expenses	503	479	261	278	281	294	358	363	343	343	334
Other Current Liabilities	-	-	455	459	547	565	658	596	514	541	543
Total Noncurrent Liabilities	1,815	1,507	1,578	2,323	1,924	2,104	2,805	3,131	3,021	2,592	2,299
Long-Term Debt	1,692	1,393	1,438	2,166	1,775	1,779	2,406	2,733	2,663	2,253	1,977
Other Noncurrent Operating Liabilities	65	71	139	157	150	325	399	398	359	339	322
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-334	-54	196	-335	-723	-390	-856	-1,392	-1,266	-1,060	-801
Total Preferred & Common Equity	-334	-54	196	-335	-723	-390	-856	-1,392	-1,266	-1,060	-801
Total Common Equity	-334	-54	196	-335	-723	-390	-856	-1,392	-1,266	-1,060	-801
Common Stock	409	438	468	407	342	367	342	318	189	234	278
Retained Earnings	-665	-326	-66	-248	-526	-215	-687	-1,169	-1,205	-1,062	-808
Accumulated Other Comprehensive Income / (Loss)	-78	-166	-205	-165	-210	-213	-182	-212	-250	-232	-271

This table presents Herbalife's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	2,725	2,688	2,771	2,725	2,647	2,602	2,654
Total Current Assets	1,384	1,322	1,371	1,346	1,226	1,214	1,245
Cash & Equivalents	533	454	527	496	398	374	403
Accounts Receivable	85	85	86	80	88	83	82
Inventories, net	537	545	525	497	502	481	515
Prepaid Expenses	229	238	233	274	238	276	245
Plant, Property, & Equipment, net	468	480	486	492	511	468	463
Total Noncurrent Assets	874	886	913	886	910	920	946
Goodwill	88	94	94	93	94	92	93
Intangible Assets	316	315	315	314	314	313	313
Other Noncurrent Operating Assets	470	476	504	479	502	516	540
Total Liabilities & Shareholders' Equity	2,725	2,688	2,771	2,725	2,647	2,602	2,654
Total Liabilities	4,087	3,910	3,921	3,828	3,684	3,639	3,608
Total Current Liabilities	986	1,227	1,241	1,165	945	976	1,285
Short-Term Debt	30	294	296	233	2.90	22	283
Accounts Payable	85	68	89	78	90	81	87
Accrued Expenses	329	317	328	335	313	317	332
Other Current Liabilities	543	548	528	520	539	557	583
Total Noncurrent Liabilities	3,102	2,683	2,680	2,663	2,739	2,663	2,323
Long-Term Debt	2,725	2,335	2,327	2,319	2,405	2,321	1,978
Other Noncurrent Operating Liabilities	377	348	354	344	334	342	345
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-1,362	-1,223	-1,150	-1,104	-1,037	-1,037	-954
Total Preferred & Common Equity	-1,362	-1,223	-1,150	-1,104	-1,037	-1,037	-954
Total Common Equity	-1,362	-1,223	-1,150	-1,104	-1,037	-1,037	-954
Common Stock	181	191	203	222	244	254	267
Retained Earnings	-1,259	-1,175	-1,115	-1,073	-1,038	-1,033	-986
Accumulated Other Comprehensive Income / (Loss)	-284	-239	-238	-253	-243	-257	-235

This table displays calculated financial ratios and metrics derived from Herbalife's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.76%	-9.87%	0.43%	-1.35%	10.48%	-0.30%	13.63%	4.71%	-10.31%	-2.73%	-1.37%
EBITDA Growth	-22.54%	15.43%	-16.78%	27.02%	1.61%	-12.18%	10.64%	10.37%	-19.72%	-29.70%	6.71%
EBIT Growth	-31.93%	16.14%	-21.19%	34.80%	1.34%	-11.73%	15.97%	10.76%	-21.35%	-35.95%	5.04%
NOPAT Growth	-30.48%	8.13%	-19.73%	-14.22%	55.81%	-10.32%	18.09%	26.65%	-29.56%	-39.46%	132.04%
Net Income Growth	-41.48%	9.85%	-23.33%	-17.73%	38.66%	4.86%	19.81%	20.02%	-28.15%	-55.74%	78.83%
EPS Growth	-30.75%	16.76%	-23.33%	-17.73%	53.49%	11.11%	25.91%	49.10%	-21.79%	-56.04%	76.06%
Operating Cash Flow Growth	-33.83%	22.94%	-41.58%	60.85%	9.75%	-29.44%	37.40%	-26.77%	-23.42%	1.42%	-20.17%
Free Cash Flow Firm Growth	-88.06%	682.19%	-62.03%	107.59%	31.44%	-37.58%	45.69%	-32.66%	-23.00%	-8.72%	92.03%
Invested Capital Growth	60.86%	-16.42%	17.90%	-18.20%	-18.81%	7.92%	-8.14%	46.06%	19.30%	0.96%	12.60%
Revenue Q/Q Growth	-2.66%	-0.78%	-1.18%	1.10%	1.94%	0.70%	3.56%	-3.35%	-0.55%	0.68%	-0.15%
EBITDA Q/Q Growth	-2.84%	-2.17%	2.20%	-0.85%	-0.15%	-10.59%	5.86%	-9.26%	1.81%	-6.25%	9.23%
EBIT Q/Q Growth	-6.15%	-3.61%	3.53%	-1.39%	0.22%	-11.80%	6.66%	-11.11%	3.22%	-8.24%	11.99%
NOPAT Q/Q Growth	-1.05%	-4.18%	4.43%	-41.05%	59.44%	2.95%	4.60%	-4.85%	2.01%	-14.14%	168.42%
Net Income Q/Q Growth	-6.12%	-5.28%	6.08%	-43.22%	60.93%	2.57%	4.81%	-7.37%	5.31%	-23.71%	193.65%
EPS Q/Q Growth	2.10%	-8.31%	6.08%	-43.22%	46.67%	-0.45%	-9.18%	-4.40%	5.21%	-24.47%	194.12%
Operating Cash Flow Q/Q Growth	-20.76%	13.26%	-4.70%	13.22%	-6.85%	4.07%	-6.56%	-5.56%	-8.27%	13.49%	-8.50%
Free Cash Flow Firm Q/Q Growth	-62.15%	22.21%	-7.80%	9.13%	-0.46%	4.55%	-12.54%	-0.73%	-10.63%	21.36%	75.37%
Invested Capital Q/Q Growth	15.11%	-1.35%	2.81%	-24.18%	-7.57%	-7.65%	9.52%	2.46%	6.74%	-2.68%	15.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	80.18%	80.85%	80.96%	80.83%	81.21%	80.36%	79.24%	78.64%	77.45%	76.47%	77.88%
EBITDA Margin	12.85%	16.46%	13.64%	17.56%	16.15%	14.23%	13.85%	14.60%	13.07%	9.44%	10.22%
Operating Margin	10.36%	13.06%	10.21%	13.94%	13.96%	11.65%	11.56%	12.65%	10.48%	7.04%	7.73%
EBIT Margin	10.09%	13.01%	10.21%	13.95%	12.79%	11.33%	11.56%	12.23%	10.72%	7.06%	7.52%
Profit (Net Income) Margin	6.23%	7.59%	5.79%	4.83%	6.06%	6.38%	6.72%	7.71%	6.17%	2.81%	5.09%
Tax Burden Percent	73.27%	69.72%	71.29%	45.39%	63.89%	68.90%	72.15%	79.74%	75.64%	70.05%	150.12%
Interest Burden Percent	84.18%	83.67%	79.61%	76.31%	74.18%	81.72%	80.61%	79.04%	76.13%	56.80%	45.13%
Effective Tax Rate	26.73%	30.28%	28.71%	54.61%	36.11%	31.10%	27.85%	20.26%	24.36%	29.95%	-50.12%
Return on Invested Capital (ROIC)	57.15%	54.59%	44.17%	38.51%	73.60%	70.84%	84.00%	90.30%	48.87%	27.06%	58.79%
ROIC Less NNEP Spread (ROIC-NNEP)	44.86%	47.37%	34.20%	30.20%	61.13%	63.59%	76.36%	82.51%	44.68%	21.91%	41.83%
Return on Net Nonoperating Assets (RNNOA)	227.37%	-229.43%	319.98%	-347.62%	-129.66%	-126.70%	-143.80%	-130.10%	-73.05%	-39.29%	-86.12%
Return on Equity (ROE)	284.52%	-174.84%	364.15%	-309.10%	-56.06%	-55.86%	-59.80%	-39.79%	-24.18%	-12.23%	-27.32%
Cash Return on Invested Capital (CROIC)	10.49%	72.47%	27.74%	58.53%	94.35%	63.22%	92.49%	52.86%	31.27%	26.11%	46.94%
Operating Return on Assets (OROA)	20.73%	24.06%	18.17%	22.62%	22.02%	20.20%	22.26%	24.07%	20.10%	12.90%	13.56%
Return on Assets (ROA)	12.79%	14.03%	10.31%	7.83%	10.43%	11.37%	12.95%	15.17%	11.57%	5.13%	9.18%
Return on Common Equity (ROCE)	284.52%	-174.84%	364.15%	-309.10%	-56.06%	-55.86%	-59.80%	-39.79%	-24.18%	-12.23%	-27.32%
Return on Equity Simple (ROE_SIMPLE)	-92.31%	-633.83%	132.45%	-63.91%	-41.00%	-79.74%	-43.52%	-32.14%	-25.38%	-13.41%	-31.74%
Net Operating Profit after Tax (NOPAT)	376	407	327	280	436	391	462	585	412	250	579
NOPAT Margin	7.59%	9.10%	7.28%	6.33%	8.92%	8.03%	8.34%	10.09%	7.92%	4.93%	11.60%
Net Nonoperating Expense Percent (NNEP)	12.29%	7.21%	9.97%	8.31%	12.46%	7.25%	7.64%	7.80%	4.19%	5.15%	16.96%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	28.92%	16.62%	39.71%
Cost of Revenue to Revenue	19.82%	19.15%	19.04%	19.17%	18.79%	19.64%	20.76%	21.36%	22.55%	23.53%	22.12%
SG&A Expenses to Revenue	40.15%	39.93%	43.82%	39.72%	39.97%	39.78%	37.44%	34.67%	34.79%	36.86%	37.56%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	69.82%	67.79%	70.75%	66.90%	67.24%	68.71%	67.68%	65.99%	66.97%	69.43%	70.15%
Earnings before Interest and Taxes (EBIT)	501	581	458	618	626	552	641	710	558	357	375
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	637	736	612	778	790	694	768	847	680	478	510
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	22.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.70	1.11	1.00	1.33	1.88	1.44	1.14	0.79	0.28	0.30	0.14
Price to Earnings (P/E)	11.21	14.63	17.23	27.61	31.03	25.11	16.97	10.26	4.53	10.64	2.65
Dividend Yield	3.18%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	8.92%	6.83%	5.80%	3.62%	3.22%	3.98%	5.89%	9.74%	22.06%	9.40%	37.71%
Enterprise Value to Invested Capital (EV/IC)	5.67	8.39	6.35	10.53	19.68	13.92	14.63	8.77	3.97	3.78	2.41
Enterprise Value to Revenue (EV/Rev)	0.93	1.27	1.13	1.56	2.14	1.64	1.39	1.16	0.70	0.69	0.50
Enterprise Value to EBITDA (EV/EBITDA)	7.23	7.74	8.30	8.87	13.24	11.51	10.04	7.97	5.35	7.32	4.94
Enterprise Value to EBIT (EV/EBIT)	9.21	9.80	11.10	11.16	16.71	14.46	12.03	9.51	6.52	9.79	6.71
Enterprise Value to NOPAT (EV/NOPAT)	12.24	13.99	15.56	24.61	23.96	20.40	16.67	11.53	8.83	14.02	4.35
Enterprise Value to Operating Cash Flow (EV/OCF)	9.01	9.06	13.84	11.67	16.13	17.45	12.26	14.67	10.33	9.79	8.83
Enterprise Value to Free Cash Flow (EV/FCFF)	66.72	10.54	24.79	16.19	18.69	22.86	15.14	19.70	13.80	14.53	5.45
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-5.36	-30.32	7.38	-6.78	-3.39	-4.62	-2.84	-1.99	-2.13	-2.42	-2.82
Long-Term Debt to Equity	-5.06	-26.03	7.33	-6.47	-2.45	-4.56	-2.81	-1.96	-2.10	-2.12	-2.47
Financial Leverage	5.07	-4.84	9.36	-11.51	-2.12	-1.99	-1.88	-1.58	-1.64	-1.79	-2.06
Leverage Ratio	22.25	-12.46	35.32	-39.45	-5.37	-4.91	-4.62	-2.62	-2.09	-2.38	-2.97
Compound Leverage Factor	18.73	-10.43	28.12	-30.11	-3.99	-4.01	-3.72	-2.07	-1.59	-1.35	-1.34
Debt to Total Capital	122.95%	103.41%	88.06%	117.31%	141.81%	127.60%	154.45%	201.49%	188.77%	170.59%	154.91%
Short-Term Debt to Total Capital	6.86%	14.63%	0.58%	5.30%	39.23%	1.71%	1.46%	2.14%	2.07%	20.60%	19.43%
Long-Term Debt to Total Capital	116.08%	88.78%	87.48%	112.02%	102.57%	125.90%	152.99%	199.34%	186.70%	149.98%	135.48%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-22.95%	-3.41%	11.94%	-17.31%	-41.81%	-27.60%	-54.45%	-101.49%	-88.77%	-70.59%	-54.91%
Debt to EBITDA	2.81	2.21	2.37	2.92	3.11	2.60	3.16	3.26	3.96	5.36	4.43
Net Debt to EBITDA	1.80	1.00	0.99	1.27	1.59	1.39	1.80	2.55	3.21	4.16	3.62
Long-Term Debt to EBITDA	2.66	1.89	2.35	2.79	2.25	2.56	3.13	3.23	3.91	4.71	3.87
Debt to NOPAT	4.76	3.99	4.43	8.10	5.62	4.61	5.25	4.72	6.53	10.26	3.90
Net Debt to NOPAT	3.05	1.80	1.85	3.53	2.88	2.46	2.99	3.69	5.30	7.96	3.18
Long-Term Debt to NOPAT	4.50	3.42	4.40	7.73	4.07	4.54	5.20	4.67	6.46	9.02	3.41
Altman Z-Score	3.45	3.83	3.75	3.61	3.89	4.00	3.39	3.11	2.35	1.98	1.95
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.59	1.53	1.85	2.05	1.14	1.54	1.58	1.33	1.39	1.10	0.93
Quick Ratio	0.83	0.94	1.16	1.51	0.80	0.95	1.00	0.62	0.59	0.51	0.39
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	69	540	205	426	560	349	509	343	264	241	463
Operating Cash Flow to CapEx	271.01%	795.82%	256.14%	618.64%	771.90%	431.20%	561.25%	304.03%	225.38%	264.81%	233.93%
Free Cash Flow to Firm to Interest Expense	0.75	5.37	2.07	2.65	3.09	2.28	3.83	2.24	1.89	1.45	2.12
Operating Cash Flow to Interest Expense	5.58	6.26	3.70	3.67	3.58	2.99	4.73	3.01	2.53	2.15	1.31
Operating Cash Flow Less CapEx to Interest Expense	3.52	5.47	2.25	3.08	3.12	2.30	3.88	2.02	1.41	1.34	0.75
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.05	1.85	1.78	1.62	1.72	1.78	1.93	1.97	1.87	1.83	1.80
Accounts Receivable Turnover	53.93	58.23	64.03	54.13	59.73	64.94	68.00	77.27	75.70	66.70	66.53
Inventory Turnover	2.70	2.41	2.43	2.38	2.54	2.34	2.45	2.30	2.03	2.19	2.25
Fixed Asset Turnover	14.47	12.66	12.52	11.72	13.27	13.33	14.55	13.94	11.21	10.20	10.33
Accounts Payable Turnover	12.67	11.93	12.47	12.68	12.35	11.78	13.51	13.72	12.91	13.71	14.34
Days Sales Outstanding (DSO)	6.77	6.27	5.70	6.74	6.11	5.62	5.37	4.72	4.82	5.47	5.49
Days Inventory Outstanding (DIO)	135.34	151.31	150.19	153.23	143.53	155.83	148.72	158.61	179.83	166.40	162.06
Days Payable Outstanding (DPO)	28.80	30.59	29.28	28.78	29.56	30.99	27.01	26.61	28.27	26.63	25.45
Cash Conversion Cycle (CCC)	113.31	126.98	126.61	131.20	120.08	130.46	127.07	136.73	156.38	145.24	142.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	812	679	800	655	532	574	527	770	918	927	1,044
Invested Capital Turnover	7.53	6.00	6.07	6.09	8.25	8.83	10.07	8.95	6.17	5.49	5.07
Increase / (Decrease) in Invested Capital	307	-133	122	-146	-123	42	-47	243	149	8.80	117
Enterprise Value (EV)	4,607	5,694	5,083	6,894	10,458	7,985	7,707	6,751	3,641	3,500	2,519
Market Capitalization	3,461	4,962	4,479	5,905	9,203	7,021	6,324	4,590	1,457	1,512	674
Book Value per Share	($3.64)	($0.58)	$2.11	($3.84)	($4.63)	($2.65)	($6.50)	($12.41)	($12.93)	($10.70)	($7.95)
Tangible Book Value per Share	($8.14)	($4.92)	($2.19)	($8.51)	($7.22)	($5.37)	($9.65)	($16.09)	($17.11)	($14.83)	($11.92)
Total Capital	1,457	1,569	1,644	1,933	1,730	1,413	1,572	1,371	1,426	1,502	1,459
Total Debt	1,792	1,622	1,448	2,268	2,454	1,803	2,428	2,763	2,692	2,562	2,260
Total Long-Term Debt	1,692	1,393	1,438	2,166	1,775	1,779	2,406	2,733	2,663	2,253	1,977
Net Debt	1,146	732	604	989	1,255	964	1,383	2,161	2,184	1,987	1,845
Capital Expenditures (CapEx)	189	79	143	96	84	106	112	151	156	135	122
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-27	-118	-164	-223	-304	-292	-374	-221	-99	-144	-219
Debt-free Net Working Capital (DFNWC)	619	771	681	1,056	895	548	671	381	409	431	197
Net Working Capital (NWC)	519	542	671	954	216	524	649	351	380	122	-87
Net Nonoperating Expense (NNE)	68	68	67	66	140	80	90	138	91	107	325
Net Nonoperating Obligations (NNO)	1,146	732	604	989	1,255	964	1,383	2,161	2,184	1,987	1,845
Total Depreciation and Amortization (D&A)	137	154	154	160	164	141	127	138	122	121	135
Debt-free, Cash-free Net Working Capital to Revenue	-0.54%	-2.65%	-3.64%	-5.03%	-6.21%	-5.98%	-6.75%	-3.80%	-1.90%	-2.84%	-4.38%
Debt-free Net Working Capital to Revenue	12.48%	17.26%	15.16%	23.85%	18.30%	11.23%	12.12%	6.56%	7.86%	8.52%	3.94%
Net Working Capital to Revenue	10.46%	12.13%	14.95%	21.53%	4.42%	10.74%	11.70%	6.06%	7.29%	2.40%	-1.74%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.79	$2.06	$1.57	$1.35	$2.12	$2.26	$2.83	$4.22	$3.26	$1.44	$2.53
Adjusted Weighted Average Basic Shares Outstanding	172.60M	165.20M	166M	158.40M	140.20M	137.40M	131.50M	105.90M	98.50M	99M	100.60M
Adjusted Diluted Earnings per Share	$1.70	$1.99	$1.51	$1.29	$1.98	$2.20	$2.77	$4.13	$3.23	$1.42	$2.50
Adjusted Weighted Average Diluted Shares Outstanding	181.60M	170.60M	172.20M	165.80M	149.50M	141.60M	134.50M	108.30M	99.50M	100.20M	101.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	184.25M	185.35M	186.17M	174.84M	152.86M	147.53M	117.92M	109.77M	97.92M	99.26M	101.20M
Normalized Net Operating Profit after Tax (NOPAT)	376	407	327	432	436	391	462	585	412	250	270
Normalized NOPAT Margin	7.59%	9.10%	7.28%	9.76%	8.92%	8.03%	8.34%	10.09%	7.92%	4.93%	5.41%
Pre Tax Income Margin	8.50%	10.88%	8.13%	10.64%	9.49%	9.26%	9.32%	9.66%	8.16%	4.01%	3.39%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.46	5.78	4.61	3.84	3.46	3.61	4.82	4.63	4.01	2.15	1.72
NOPAT to Interest Expense	4.10	4.05	3.29	1.74	2.41	2.56	3.48	3.82	2.96	1.50	2.65
EBIT Less CapEx to Interest Expense	3.40	5.00	3.17	3.25	2.99	2.92	3.97	3.65	2.88	1.34	1.16
NOPAT Less CapEx to Interest Expense	2.05	3.26	1.84	1.15	1.95	1.86	2.63	2.83	1.84	0.69	2.09
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	9.85%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	428.34%	4.90%	5.08%	394.67%	252.97%	5.37%	247.85%	226.14%	45.66%	7.74%	3.26%

This table displays calculated financial ratios and metrics derived from Herbalife's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-9.49%	-2.38%	-6.27%	-5.65%	-1.07%	2.90%	0.97%	-2.50%	-3.20%	-0.63%
EBITDA Growth	-20.67%	-0.59%	-45.76%	-17.34%	-22.34%	-27.69%	3.41%	-31.35%	17.03%	62.40%
EBIT Growth	-22.18%	5.46%	-53.95%	-20.80%	-26.93%	-37.23%	1.99%	-43.35%	18.01%	90.86%
NOPAT Growth	-26.78%	11.00%	-45.48%	-19.92%	-38.51%	-57.18%	-22.63%	-64.38%	29.31%	1,020.16%
Net Income Growth	-29.98%	42.41%	-70.16%	-30.75%	-47.93%	-81.25%	-17.06%	-92.15%	10.75%	1,644.12%
EPS Growth	-23.85%	40.00%	-69.79%	-31.82%	-48.19%	-82.14%	-17.24%	-91.67%	6.98%	1,650.00%
Operating Cash Flow Growth	-20.91%	-37.24%	-64.60%	37.25%	14.37%	79.29%	-70.13%	-24.41%	25.00%	-27.58%
Free Cash Flow Firm Growth	98.64%	58.07%	-44.82%	17.25%	-1,464.63%	131.82%	132.86%	199.63%	606.47%	942.12%
Invested Capital Growth	14.51%	19.30%	20.08%	16.22%	10.73%	0.96%	2.20%	-1.46%	-5.03%	12.60%
Revenue Q/Q Growth	-7.01%	-8.83%	6.04%	4.94%	-2.49%	-5.17%	4.06%	1.33%	-3.18%	-2.65%
EBITDA Q/Q Growth	-4.87%	-33.15%	-15.99%	54.71%	-10.62%	-37.75%	20.14%	2.71%	52.36%	-13.62%
EBIT Q/Q Growth	-5.39%	-39.69%	-20.70%	75.04%	-12.72%	-48.19%	28.85%	-2.78%	81.83%	-16.21%
NOPAT Q/Q Growth	-1.18%	-30.03%	-11.55%	30.93%	-24.11%	-51.27%	59.81%	-39.72%	175.50%	322.11%
Net Income Q/Q Growth	-4.97%	-33.82%	-46.14%	104.44%	-28.55%	-76.17%	138.24%	-80.66%	908.51%	275.32%
EPS Q/Q Growth	-5.68%	-32.53%	-48.21%	106.90%	-28.33%	-76.74%	140.00%	-79.17%	820.00%	280.43%
Operating Cash Flow Q/Q Growth	-29.55%	-22.99%	-13.81%	193.51%	-41.30%	20.73%	-85.64%	642.75%	-2.93%	-30.05%
Free Cash Flow Firm Q/Q Growth	96.90%	-4,265.90%	-26.40%	51.56%	41.46%	188.78%	30.53%	46.86%	197.57%	82.68%
Invested Capital Q/Q Growth	5.74%	6.74%	3.70%	-0.71%	0.75%	-2.68%	4.97%	-4.27%	-2.90%	15.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.99%	77.51%	76.15%	77.05%	76.34%	76.33%	77.46%	77.90%	78.34%	77.85%
EBITDA Margin	13.72%	10.06%	7.97%	11.75%	10.77%	7.07%	8.16%	8.27%	13.02%	11.55%
Operating Margin	11.38%	7.53%	5.63%	9.39%	8.33%	4.59%	5.69%	6.28%	10.25%	8.82%
EBIT Margin	11.38%	7.53%	5.63%	9.39%	8.41%	4.59%	5.69%	5.46%	10.25%	8.82%
Profit (Net Income) Margin	6.35%	4.61%	2.34%	4.56%	3.34%	0.84%	1.92%	0.37%	3.82%	14.73%
Tax Burden Percent	72.81%	84.47%	94.21%	70.47%	61.85%	57.63%	71.47%	38.52%	67.14%	338.21%
Interest Burden Percent	76.59%	72.44%	44.11%	68.88%	64.25%	31.72%	47.29%	17.45%	55.55%	49.39%
Effective Tax Rate	27.19%	15.53%	5.79%	29.53%	38.15%	42.37%	28.53%	61.48%	32.86%	-238.21%
Return on Invested Capital (ROIC)	53.83%	39.22%	31.13%	37.95%	28.58%	14.52%	21.43%	12.99%	37.06%	151.18%
ROIC Less NNEP Spread (ROIC-NNEP)	52.66%	38.27%	29.45%	36.69%	27.49%	13.47%	20.13%	11.70%	35.12%	141.66%
Return on Net Nonoperating Assets (RNNOA)	-84.14%	-62.58%	-48.66%	-61.85%	-47.70%	-24.16%	-37.29%	-21.73%	-66.81%	-291.64%
Return on Equity (ROE)	-30.31%	-23.35%	-17.53%	-23.90%	-19.13%	-9.63%	-15.86%	-8.74%	-29.75%	-140.46%
Cash Return on Invested Capital (CROIC)	36.65%	31.27%	22.00%	22.65%	21.90%	26.11%	22.60%	22.14%	28.40%	46.94%
Operating Return on Assets (OROA)	21.36%	14.12%	10.46%	16.99%	15.51%	8.39%	10.82%	10.24%	19.06%	15.91%
Return on Assets (ROA)	11.91%	8.64%	4.35%	8.25%	6.16%	1.53%	3.66%	0.69%	7.11%	26.57%
Return on Common Equity (ROCE)	-30.31%	-23.35%	-17.53%	-23.90%	-19.13%	-9.63%	-15.86%	-8.74%	-29.75%	-140.46%
Return on Equity Simple (ROE_SIMPLE)	-22.40%	0.00%	-20.64%	-19.63%	-16.89%	0.00%	-13.24%	-7.91%	-9.08%	0.00%
Net Operating Profit after Tax (NOPAT)	107	75	66	87	66	32	51	31	85	360
NOPAT Margin	8.29%	6.36%	5.30%	6.62%	5.15%	2.65%	4.06%	2.42%	6.88%	29.83%
Net Nonoperating Expense Percent (NNEP)	1.17%	0.95%	1.68%	1.25%	1.08%	1.05%	1.29%	1.29%	1.94%	9.51%
Return On Investment Capital (ROIC_SIMPLE)	-	5.27%	-	-	-	2.14%	-	-	-	24.69%
Cost of Revenue to Revenue	22.01%	22.49%	23.85%	22.95%	23.66%	23.67%	22.54%	22.10%	21.66%	22.16%
SG&A Expenses to Revenue	34.61%	37.03%	38.01%	35.05%	35.53%	39.04%	38.93%	39.21%	35.80%	36.19%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	66.60%	69.98%	70.52%	67.66%	68.01%	71.74%	71.77%	71.63%	68.09%	69.02%
Earnings before Interest and Taxes (EBIT)	147	89	71	123	108	56	72	70	127	107
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	178	119	100	154	138	86	103	106	162	140
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.41	0.28	0.31	0.26	0.28	0.30	0.20	0.21	0.14	0.14
Price to Earnings (P/E)	11.97	4.53	6.25	5.80	7.43	10.64	7.26	12.67	8.36	2.65
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	8.36%	22.06%	16.01%	17.24%	13.46%	9.40%	13.77%	7.89%	11.96%	37.71%
Enterprise Value to Invested Capital (EV/IC)	5.08	3.97	3.94	3.60	3.61	3.78	3.09	3.23	2.86	2.41
Enterprise Value to Revenue (EV/Rev)	0.83	0.70	0.73	0.68	0.68	0.69	0.59	0.60	0.52	0.50
Enterprise Value to EBITDA (EV/EBITDA)	6.54	5.35	6.43	6.18	6.75	7.32	6.26	6.79	5.53	4.94
Enterprise Value to EBIT (EV/EBIT)	8.08	6.52	8.11	7.92	8.83	9.79	8.40	9.55	7.71	6.71
Enterprise Value to NOPAT (EV/NOPAT)	10.80	8.83	10.68	10.29	11.83	14.02	12.61	15.51	11.97	4.35
Enterprise Value to Operating Cash Flow (EV/OCF)	11.36	10.33	13.99	11.17	10.92	9.79	9.25	10.30	8.28	8.83
Enterprise Value to Free Cash Flow (EV/FCFF)	14.79	13.80	19.54	17.10	17.34	14.53	13.82	14.48	9.79	5.45
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.02	-2.13	-2.15	-2.28	-2.31	-2.42	-2.32	-2.26	-2.37	-2.82
Long-Term Debt to Equity	-2.00	-2.10	-1.91	-2.02	-2.10	-2.12	-2.32	-2.24	-2.07	-2.47
Financial Leverage	-1.60	-1.64	-1.65	-1.69	-1.74	-1.79	-1.85	-1.86	-1.90	-2.06
Leverage Ratio	-2.07	-2.09	-2.06	-2.17	-2.21	-2.38	-2.36	-2.46	-2.61	-2.97
Compound Leverage Factor	-1.59	-1.51	-0.91	-1.50	-1.42	-0.76	-1.12	-0.43	-1.45	-1.47
Debt to Total Capital	197.80%	188.77%	186.95%	178.16%	176.20%	170.59%	175.59%	179.45%	173.01%	154.91%
Short-Term Debt to Total Capital	2.12%	2.07%	20.88%	20.10%	16.06%	20.60%	0.21%	1.66%	21.68%	19.43%
Long-Term Debt to Total Capital	195.68%	186.70%	166.07%	158.06%	160.14%	149.98%	175.38%	177.79%	151.33%	135.48%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-97.80%	-88.77%	-86.95%	-78.16%	-76.20%	-70.59%	-75.59%	-79.45%	-73.01%	-54.91%
Debt to EBITDA	4.12	3.96	4.51	4.76	5.00	5.36	5.01	5.29	4.84	4.43
Net Debt to EBITDA	3.33	3.21	3.73	3.81	4.03	4.16	4.18	4.45	3.98	3.62
Long-Term Debt to EBITDA	4.08	3.91	4.01	4.22	4.55	4.71	5.01	5.24	4.23	3.87
Debt to NOPAT	6.81	6.53	7.49	7.92	8.78	10.26	10.10	12.08	10.48	3.90
Net Debt to NOPAT	5.50	5.30	6.19	6.33	7.07	7.96	8.43	10.15	8.61	3.18
Long-Term Debt to NOPAT	6.74	6.46	6.65	7.03	7.98	9.02	10.09	11.97	9.16	3.41
Altman Z-Score	1.94	1.78	1.66	1.66	1.72	1.62	1.75	1.75	1.62	1.62
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.40	1.39	1.08	1.11	1.16	1.10	1.30	1.24	0.97	0.93
Quick Ratio	0.63	0.59	0.44	0.49	0.49	0.51	0.51	0.47	0.38	0.39
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1.68	-73	-93	-45	-26	23	30	45	133	243
Operating Cash Flow to CapEx	184.62%	125.23%	152.48%	354.05%	255.95%	272.24%	41.95%	282.37%	367.16%	270.82%
Free Cash Flow to Firm to Interest Expense	-0.05	-1.69	-2.35	-1.17	-0.68	0.47	0.80	0.78	2.36	3.68
Operating Cash Flow to Interest Expense	2.02	1.24	1.17	3.53	2.07	1.94	0.36	1.78	1.76	1.05
Operating Cash Flow Less CapEx to Interest Expense	0.92	0.25	0.40	2.53	1.26	1.23	-0.50	1.15	1.28	0.66
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.88	1.87	1.86	1.81	1.85	1.83	1.90	1.88	1.86	1.80
Accounts Receivable Turnover	61.24	75.70	60.56	59.42	61.13	66.70	58.67	59.63	61.93	66.53
Inventory Turnover	2.20	2.03	2.09	2.13	2.26	2.19	2.25	2.30	2.22	2.25
Fixed Asset Turnover	11.90	11.21	10.97	10.60	10.47	10.20	10.24	10.57	10.47	10.33
Accounts Payable Turnover	13.14	12.91	14.72	12.15	14.40	13.71	14.92	13.64	13.67	14.34
Days Sales Outstanding (DSO)	5.96	4.82	6.03	6.14	5.97	5.47	6.22	6.12	5.89	5.49
Days Inventory Outstanding (DIO)	166.17	179.83	174.67	171.16	161.39	166.40	162.29	158.39	164.27	162.06
Days Payable Outstanding (DPO)	27.79	28.27	24.80	30.03	25.35	26.63	24.46	26.76	26.70	25.45
Cash Conversion Cycle (CCC)	144.34	156.38	155.90	147.27	142.01	145.24	144.05	137.76	143.47	142.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	860	918	952	945	952	927	973	932	905	1,044
Invested Capital Turnover	6.50	6.17	5.87	5.73	5.55	5.49	5.27	5.37	5.39	5.07
Increase / (Decrease) in Invested Capital	109	149	159	132	92	8.80	21	-14	-48	117
Enterprise Value (EV)	4,367	3,641	3,751	3,405	3,441	3,500	3,006	3,007	2,583	2,519
Market Capitalization	2,145	1,457	1,577	1,310	1,385	1,512	996	1,039	724	674
Book Value per Share	($12.63)	($12.93)	($12.49)	($11.63)	($11.15)	($10.70)	($10.40)	($10.38)	($9.47)	($7.95)
Tangible Book Value per Share	($16.37)	($17.11)	($16.67)	($15.77)	($15.26)	($14.83)	($14.48)	($14.42)	($13.50)	($11.92)
Total Capital	1,393	1,426	1,406	1,472	1,448	1,502	1,371	1,306	1,307	1,459
Total Debt	2,755	2,692	2,629	2,622	2,552	2,562	2,408	2,343	2,261	2,260
Total Long-Term Debt	2,725	2,663	2,335	2,327	2,319	2,253	2,405	2,321	1,978	1,977
Net Debt	2,222	2,184	2,175	2,096	2,056	1,987	2,010	1,969	1,859	1,845
Capital Expenditures (CapEx)	38	43	30	38	31	35	33	36	27	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-105	-99	-66	-100	-82	-144	-114	-115	-160	-219
Debt-free Net Working Capital (DFNWC)	428	409	389	426	413	431	284	259	243	197
Net Working Capital (NWC)	398	380	95	131	181	122	282	238	-40	-87
Net Nonoperating Expense (NNE)	25	21	37	27	23	22	27	26	38	182
Net Nonoperating Obligations (NNO)	2,222	2,184	2,175	2,096	2,056	1,987	2,010	1,969	1,859	1,845
Total Depreciation and Amortization (D&A)	30	30	29	31	30	30	31	36	34	33
Debt-free, Cash-free Net Working Capital to Revenue	-2.00%	-1.90%	-1.28%	-1.99%	-1.64%	-2.84%	-2.24%	-2.28%	-3.19%	-4.38%
Debt-free Net Working Capital to Revenue	8.17%	7.86%	7.59%	8.46%	8.22%	8.52%	5.60%	5.14%	4.86%	3.94%
Net Working Capital to Revenue	7.61%	7.29%	1.86%	2.59%	3.59%	2.40%	5.55%	4.71%	-0.81%	-1.74%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.84	$0.56	$0.30	$0.60	$0.43	$0.11	$0.24	$0.05	$0.47	$1.77
Adjusted Weighted Average Basic Shares Outstanding	98M	98.50M	98.50M	99.10M	99.20M	99M	99.70M	100.60M	100.90M	100.60M
Adjusted Diluted Earnings per Share	$0.83	$0.56	$0.29	$0.60	$0.43	$0.10	$0.24	$0.05	$0.46	$1.75
Adjusted Weighted Average Diluted Shares Outstanding	98.80M	99.50M	100.20M	99.50M	100.40M	100.20M	100.70M	101.70M	101.90M	101.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	97.88M	97.92M	98.92M	99.00M	99.11M	99.26M	99.97M	100.72M	100.79M	101.20M
Normalized Net Operating Profit after Tax (NOPAT)	107	75	66	87	66	32	51	56	85	75
Normalized NOPAT Margin	8.29%	6.36%	5.30%	6.62%	5.15%	2.65%	4.06%	4.39%	6.88%	6.17%
Pre Tax Income Margin	8.72%	5.45%	2.48%	6.47%	5.40%	1.46%	2.69%	0.95%	5.69%	4.36%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.27	2.05	1.79	3.21	2.80	1.13	1.90	1.21	2.25	1.61
NOPAT to Interest Expense	3.11	1.73	1.69	2.26	1.71	0.65	1.36	0.54	1.51	5.44
EBIT Less CapEx to Interest Expense	3.18	1.06	1.02	2.22	1.99	0.41	1.03	0.58	1.77	1.22
NOPAT Less CapEx to Interest Expense	2.02	0.74	0.92	1.27	0.91	-0.06	0.49	-0.09	1.03	5.05
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	81.51%	45.66%	15.53%	4.25%	5.26%	7.74%	3.35%	8.90%	8.08%	3.26%

Frequently Asked Questions About Herbalife's Financials

When does Herbalife's financial year end?

According to the most recent income statement we have on file, Herbalife's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Herbalife's net income changed over the last 10 years?

In the past 10 years, Herbalife's net income has ranged from $142.20 million in 2023 to $447.20 million in 2021, and is currently $254.30 million as of their latest financial filing in 2024. Check out Herbalife's forecast to explore projected trends and price targets.

What is Herbalife's operating income?

Herbalife's total operating income in 2024 was $385.90 million, based on the following breakdown:

Total Gross Profit: $3.89 billion
Total Operating Expenses: $3.50 billion

How has Herbalife revenue changed over the last 10 years?

Over the last 10 years, Herbalife's total revenue changed from $4.96 billion in 2014 to $4.99 billion in 2024, a change of 0.7%.

How much debt does Herbalife have?

Herbalife's total liabilities were at $3.53 billion at the end of 2024, a 8.8% decrease from 2023, and a 31.2% increase since 2014.

How much cash does Herbalife have?

In the past 10 years, Herbalife's cash and equivalents has ranged from $415.30 million in 2024 to $1.28 billion in 2017, and is currently $415.30 million as of their latest financial filing in 2024.

How has Herbalife's book value per share changed over the last 10 years?

Over the last 10 years, Herbalife's book value per share changed from -3.64 in 2014 to -7.95 in 2024, a change of 118.2%.

Related Companies

This page (NYSE:HLF) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Herbalife (HLF) Financials

Frequently Asked Questions About Herbalife's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Herbalife (HLF) Financials

Annual Income Statements for Herbalife

Quarterly Income Statements for Herbalife

Annual Cash Flow Statements for Herbalife

Quarterly Cash Flow Statements for Herbalife

Annual Balance Sheets for Herbalife

Quarterly Balance Sheets for Herbalife

Annual Metrics and Ratios for Herbalife

Quarterly Metrics and Ratios for Herbalife

Frequently Asked Questions About Herbalife's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools